Issue 99, 2015

Small molecular nanomedicines made from a camptothecin dimer containing a disulfide bond

Abstract

A small molecular camptothecin (CPT) dimer could self-assemble into stable nanoparticles in aqueous solution, which was characterized by TEM and DLS. These nanomedicines could be internalized by cancer cells as revealed by confocal laser scanning microscopy, and indicated high cellular proliferation inhibition toward HeLa and HepG2 cells with low IC50 values and reduction-responsive cytotoxicity towards HeLa cells. The feasible assembly method and outstanding properties of CPT–NPs provide an alternative approach for exploring new nanomedicines for cancer therapy.

Graphical abstract: Small molecular nanomedicines made from a camptothecin dimer containing a disulfide bond

Supplementary files

Article information

Article type
Communication
Submitted
11 Sep 2015
Accepted
16 Sep 2015
First published
21 Sep 2015

RSC Adv., 2015,5, 81499-81501

Author version available

Small molecular nanomedicines made from a camptothecin dimer containing a disulfide bond

Q. Pei, X. Hu, Z. Li, Z. Xie and X. Jing, RSC Adv., 2015, 5, 81499 DOI: 10.1039/C5RA18586F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements